Diagnostic challenges arise due to the low incidence of TNF-a antagonist-induced granulomatosis, wide variability in exposure duration at symptom onset, and possible presence of symptoms due to the underlying disease (e.g., rheumatoid arthritis or Crohn’s disease) (137, 138). This evidence concerns the gene TNF and rheumatoid arthritis.